Clinical Pharmacology Services
The experience you need to make rapid “go/no-go” decisions
We inform decision-making and accelerate development by navigating the complexities of early phase studies, anticipating risks and opportunities and applying data-driven insights.
Built for success
Fortrea has more than 250 team members fully dedicated to early phase studies.
Deep experience
Our clinical pharmacology team brings over 30 years of direct drug development experience.
A vast site network
Optimize your early phase studies with 300+ investigator sites across the globe.
Informed decisions for asset development
Fortrea provides the link between preclinical data and new treatments for patients. Our dedicated scientists and clinicians deliver comprehensive drug safety, tolerability, pharmacokinetic and pharmacodynamic data—and a complete in-house team to enable you to scrutinize development progress and deliver unique insights that inform critical decisions. As one of the largest early stage clinical research organizations in the world, we offer a comprehensive suite of pharmacology services to manage every step of your early clinical development.
The expertise to manage complexities
As we manage the conduct of your complex study, we never take our eyes off the two critical focal points—scientific integrity and human subject safety. Fortrea is built to manage the ever-growing complexity of product development with end-to-end patient safety solutions. Our integrated clinical study platform handles multisite hybrid study designs, rapid-sequence dose escalations, sophisticated biomarker or imaging exploratory endpoints, extemporaneous investigational product preparation and more.
Early phase experience that matters
In the past five years we have:
A flexible model delivers the right support
You only need access to the resources that matter most to your study, and you shouldn’t have to deal with a bigger footprint than you need. We understand. That’s why we deliver the right combination of strategy and execution, resources and tools that help you meet your end goals.
We offer you a deep, experienced team focused on this crucial phase of molecule development and deliver results as you introduce your compound in humans and move to proof-of-concept. Let us partner with you as you transition into the clinic with an eye toward future phases.
